frz,4.00tff BARE ESCENTUALS October 17, 2011

Size: px
Start display at page:

Download "frz,4.00tff BARE ESCENTUALS October 17, 2011"

Transcription

1 2011 OCT 1 P 1 : 1 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD CITIZEN PETITION In reference to: Docket No. PDA-1978 N-0018, RIN 0910 ZA40 Bare Escentuals Beauty, Inc. ("Bare Escentuals") is a manufacturer and marketer of personal care products including powder-based makeup products that are intended for use as both cosmetics and over-the-counter (OTC) sunscreen drug products. All Bare Escentuals cosmeticsunscreen products have been tested and provide effective levels of UVA and UVB protection. These products meet a significant consumer need: they are beauty products that are also skin care products, and women use them to obtain daily sun protection with the convenience of their daily makeup application. Thus, these products provide a meaningful contribution to the public health. In June 2011, when FDA promulgated its final sunscreen labeling rule (21 CFR ), it stated (for the first time in the 30-year history of the sunscreen monograph) that it does not consider a powder sunscreen dosage form to be eligible for review under the OTC monograph process. We respectfully request that FDA reconsider this position. Accordingly, Bare Escentuals submits this petition to request that FDA consider makeup powder dosage forms of OTC sunscreen drug products to be eligible for inclusion in the sunscreen monograph, and to consider such products to be generally recognized as safe and effective (GRASE) when they comply with the sunscreen testing and other applicable requirements of the monograph (and the final sunscreen labeling rule). The basis for this request is that: frz,4.00tff BARE ESCENTUALS 71 Stevenson Street San Francisco, California BAREESCENTUALS.COM

2 Page 2 1. Powder dosage forms of sunscreens (including makeup powders) were marketed in the United States before the beginning of the OTC Drug Review in 1972, and powder dosage forms were reviewed by FDA's Advisory Review Panel on OTC Topical Analgesic, Antirheumatic, Otic, Burn, and Sunburn Prevention and Treatment Products ("Advisory Panel") as part of its assessment of the safety and effectiveness of sunscreens covered by the OTC Drug Review; 2. A makeup powder dosage form is "suitable for topical administration" within the meaning of the sunscreen monograph and meets all legal conditions for inclusion in the monograph; 3. A conclusion that a makeup powder dosage form is covered by the sunscreen monograph is consistent with FDA's historical approach to the monograph; and 4. Excluding makeup powder dosage forms from the sunscreen monograph would reduce the number of sunscreens available to consumers for daily use and would eliminate a sunscreen option for persons who prefer this dosage form. This would be detrimental to the public health. A. Action Requested FDA's June 2011 statements on sunscreen powder dosage forms appear in two documents. In an advance notice of proposed rulemaking (ANPR), FDA stated: In response to the August 27, 2007 proposed rule for OTC sunscreen products..., several submissions recommended that we include the following dosage forms in the final sunscreen monograph...: Wipes Towelettes Powders Body washes Shampoos We currently do not consider these dosage forms eligible for review under the OTC monograph process. We were unable to identify any sunscreen products in wipe, towelette, powder, body wash, or shampoo dosage forms that were marketed OTC before the OTC Drug Review began. * * * We also have not received any time and extent applications for OTC sunscreen products formulated as wipes, towelettes, powders, body washes or shampoos. Therefore, sunscreens formulated as wipes, towelettes, powders, body washes, or shampoos are not currently eligible for review under the OTC sunscreen monograph. 76 FR 35669, (June 17, 2011).

3 I 1 Petition to Revise Sunscreen Guidance Documents Page 3 In its Draft Guidance for Industry: Enforcement Policy OTC Sunscreen Drug Products Marketed Without an Approved Application (June 2011) ("Draft Guidance"), FDA referred to the above ANPR, stating: The 2011 ANPR also listed those dosage forms that we did not consider currently eligible for review for potential inclusion in the OTC sunscreen monograph: wipes 1 towelettes 1 powders I body washes shampoos. Draft Guidance at 8. We respectfully request that FDA consider makeup powder dosage forms of OTC sunscreen drug products to be eligible for inclusion in the OTC sunscreen monograph and revise the abovecited documents to refer to "Powders (other than makeup powders)." 1 The factual and legal basis for this request is provided in section B, below. In the Draft Guidance, FDA stated Manufacturers of OTC sunscreen products in dosage forms that are not currently considered eligible for the OTC Drug Review may submit the information needed to support the eligibility of these products. In the 2011 ANPR, we invite submitters to identify any additional sunscreen dosage forms that may be eligible for potential inclusion in the OTC sunscreen monograph based on marketing prior to the commencement of the OTC Drug Review in This petition both provides information about the marketing of sunscreens in makeup powder dosage form prior to 1972 (section B.1 below) and explains why, even if there were no powder dosage forms marketed prior to 1972, makeup powder dosage forms meet all legal conditions for inclusion in the monograph (section B.2 below).3 1 Although Bare Escentual's products are limited to makeup powders, the conclusions in this petition apply to powder dosage forms in general. Therefore, FDA could respond to this petition by excluding "Powders" from the list of dosage forms that it does not consider currently eligible for review under the OTC sunscreen monograph. 2 The comment period for the ANPR was extended to. 76 FR (Sept. 14, 2011). 3 This petition does not request a change in the wording of the sunscreen monograph, 21 CFR Part 352, because no such change is needed, but this petition is analogous to a petition to amend the monograph under 21 CFR (a)(12)(i), and is consistent with section III B of FDA's Guidance for Industry Time and Extent Applications for Nonprescription Drug Products (Sept. 2011).

4 Page 4 B. Statement of Grounds We request that FDA consider makeup powder dosage forms of OTC sunscreen drug products to be eligible for inclusion in the OTC sunscreen monograph for the following reasons: 1. Powder dosage forms of sunscreens (including makeup powders) were marketed in the United States before the beginning of the OTC Drug Review in 1972, and powder dosage forms were reviewed by the Advisory Panel as part of its assessment of the safety and effectiveness of sunscreens covered by the OTC Drug Review PDA has focused on May 1972 as the date on or before which sunscreen powder dosage forms had to be marketed in the United States in order to be eligible for the OTC Drug Review. In its Draft Guidance, FDA said that OTC sunscreen products in powder dosage form "are not currently eligible for review under the OTC sunscreen monograph, because we lack the evidence that such products existed in the OTC drug marketplace on or before May, 1972." Draft Guidance at 8. However, we have identified several powder products intended for use as sunscreens that were marketed in the United States prior to May These include the following: Lablache Face Powder: Advertisements depicting claims for this product were published in at least five U.S. magazines from 1898 to The product was described as a tinted powder that "prevents and cures sunburn." Claims for the product included, "Lablache Face Powder not only cures sunburn..., but it prevents such disagreeable conditions if applied before exposure to the sun..." (Appendix A.) This product contained zinc oxide, among other ingredients, according to the Pharmaceutical Record of November 3, 1892 (Appendix E) and according to Harvey W. Wiley's 1916 publication 1001 Tests of Foods, Beverages and Toilet Accessories, Good and Otherwise ("Wiley") (Appendix F). Mennen's Borated Talcum Toilet Powder: Advertisements depicting labeling and claims for this product were published in at least nine U.S. magazines during Claims stated that, "When used daily, Mennen's keeps the skin smooth and healthy, relieves and prevents Sunburn,... and all skin troubles of summer. Makes possible the attractive, evenly browned complexion without burning." (Appendix B.) This product contained talc and boric acid, among other ingredients, according to Wiley (Appendix F). Nadine Face Powder: Advertisements depicting labeling and claims for this product were published in at least twelve U.S. magazines and newspapers from 1911 to The product was described as a tinted powder that "prevents sunburn." (Appendix C.) It contained zinc oxide, among other ingredients, according to Wiley (Appendix F).

5 Page 5 Nvsis Talcum: Advertisements depicting labeling and claims for this product were published in at least two U.S. magazines during It is described as a talcum powder that "produc[es] a scarcely visible veil against the light-rays which, acting upon the inner, or true skin, cause sunburn." (Appendix D.) In 1946, in their book Cosmetics and Dermatitis, Drs. Schwartz and Peck described a variety of sunscreen preparations, including powders ("Schwartz & Peck") (Appendix G). 4 They stated, in the Chapter "Suntan Preparations": Heavily pigmented preparations (liquids, creams, or powders) will prevent or reduce the passage of the ultraviolet radiation, i.e., cast a shadow upon the portion of the skin to which they are applied. Of course, while preventing sunburn, such preparations will prevent also suntan. Zinc oxide, calamine, and titanium dioxide are most effective in this regard. * * * Powders to prevent sunburn can be prepared by mixing zinc or titanium oxides with magnesium or zinc stearates. The stearates cause the titanium oxide to adhere better to the skin. Magnesium oxide and precipitated chalk may also be used as extenders for sunburn-preventive powders." The 1973 United States Dispensatory, which described drugs found in the scientific literature prior to that date, notes that titanium dioxide was formulated "as a protective against sunburn... in ointments or lotions, * * * in other protective preparations, and in dusting powders and face powders." (Appendix H.)5 The records described above include both literature disseminated to lay consumers as well as medical and scientific literature. These records corroborate each other and consistently demonstrate that sunscreens were on the U.S. market in powder dosage form prior to This fact was known to the Advisory Panel. In the 1978 proposed monograph on sunscreen OTC drug products, which consisted of the unaltered conclusions and recommendations of the Panel, the Panel reviewed each of the sunscreen active ingredients that it deemed to be safe and effective. In particular, the Panel reviewed effectiveness data on titanium dioxide in powder form. Quoting Schwartz & Peck and the United States Dispensatory, the Panel stated It [titanium dioxide] is used in ointments and lotions at a concentration of 15 to 25 percent as a protective against sunburn. It is also used in other protective preparations and in dusting powders and face powders... * * * Schwartz and Peck reported that 4 Schwartz, L. and S. M. Peck, "Cosmetics and Dermatitis," Paul B. Hoeber, Inc., New York (1946), pp The United States Dispensatory, 27th Ed., Edited by A. Osol and R. Pratt, J. B. Lippincott and Co., Philadelphia (1973), p

6 Page 6 "Heavily pigmented preparations (liquids, creams or powders) will prevent or reduce the passage of the UV radiation" but, "while preventing sunburn, such preparations will prevent also suntan. Zinc oxide, calamine, and titanium dioxide are most effective in this regard" FR 38206, (August 25, 1978). This and other information enabled the Panel to conclude that, "[biased on the available data,... titanium dioxide is an effective sunscreen ingredient for OTC use." Id. Thus, it is clear from the language of the proposed monograph that both the Panel and FDA were aware in 1978 of powder dosage forms that were effective sunscreens. Further, both the Panel and FDA relied on information about those dosage forms when reaching their overall conclusions about the safety and effectiveness of sunscreens in the proposed monograph. Accordingly, notwithstanding FDA's statement that it "lack[s] the evidence that such products existed in the OTC drug marketplace on or before May, 1972" (Draft Guidance at 8), in fact powder dosage forms of sunscreens (including makeup powders) were marketed in the United States before the beginning of the OTC Drug Review in 1972, and powder dosage forms were reviewed by the Advisory Panel as part of its assessment of the safety and effectiveness of sunscreens covered by the OTC Drug Review. Therefore, makeup powder dosage forms are covered by the OTC Drug Review and the sunscreen monograph.' 2. A makeup powder dosage form is "suitable for topical administration" within the meaning of the sunscreen monograph and meets all legal conditions for inclusion in the monograph Even if (notwithstanding the discussion in section B.1 above) FDA concludes that powder dosage forms of sunscreens were not available prior to 1972, makeup powder dosage forms nevertheless meet all legal conditions for inclusion in the monograph. 6 In the ANPR, FDA states, "To determine eligibility for the OTC Drug Review, we must have actual product labeling or a facsimile of labeling that documents the conditions of marketing of the product prior to May 1972 (21 CFR (a)(2))." 76 FR 35669, (June 17, 2011). However, the regulation cited by FDA is a procedural regulation that governed only submissions for review by an advisory panel after publication of the original Federal Register notice calling for data to establish a monograph and prior to the publication of a proposed monograph. Neither this nor any other regulation requires the submission of labeling (or any other specific evidence) to support a determination made after the publication of a proposed monograph that a dosage form (such as makeup powders) is properly covered by that monograph. The information provided in this petition about pre-1972 powder sunscreens is sufficiently specific to document the conditions of marketing of such products in the United States prior to May 1972.

7 Page 7 a. The monograph covers any condition for use that is consistent with the terms of the monograph and is substantially indistinguishable from the conditions reviewed by the Advisory Panel The fundamental principle of the OTC Drug Review is that a manufacturer may launch a newly marketed OTC drug product without the need for an approved new drug application (NDA), so long as the product is consistent with the terms of an OTC drug monograph with respect to active ingredients and conditions of use. Under 201(p) of the Federal Food, Drug, and Cosmetic Act, the active ingredients and conditions of use that may be marketed under an OTC drug monograph are not "new drugs" that require an approved NDA because: An advisory panel and/or FDA have concluded that they are "generally recognized... as safe and effective," and Active ingredients and conditions of use reviewed by an advisory panel and included in a proposed monograyh are considered to have "been used to a material extent [and] for a material time..."/ If a newly marketed OTC drug product varies significantly from the conditions of use on which the monograph is based, the product can be considered a "new drug" that is not covered by the monograph. 21 CFR 310.3(h). However, insignificant variations do not cause a product to become a "new drug." In determining whether a product is a "new drug," FDA has applied a "substantially indistinguishable" standard. This standard was first articulated in a September 23, 1977 letter from FDA to a drug manufacturer. In that letter, FDA stated:... an ingredient may legally meet the criterion [that an ingredient be used to a material extent and for a material time under its labeled conditions of use] without having been marketed under the precise conditions of use sought to [be] included in an OTC monograph if it has been marketed to a material extent and for a material time under other conditions of use that, although different, are substantially indistinguishable in all respects relevant to the drug's safety and effectiveness. By "substantially indistinguishable" conditions of use, I mean conditions of use that are similar enough to each other that experts can reliably conclude that knowledge about the safety and effectiveness of a drug derived from experience with its use under one set of conditions is applicable to the evaluation of the safety and effectiveness of its use under the conditions for which approval is sought. 7 FDA regulations specify that active ingredients limited to prescription use as of May 11, 1972, or active ingredients at a dosage level higher than that available OTC on December 4, 1975, may be considered "new drugs" that may not be marketed unless they are the subject of a determination that they are generally recognized as safe and effective. 21 CFR However, these dates were not considered by advisory panels for purposes of the review of active ingredients and conditions of use. See e.g., 21 CFR

8 Page 8 FDA letter to Richardson-Merrell, Inc. (September 23, 1977) (Appendix I). As FDA explained, the "substantially indistinguishable" standard reflects that the law "... may be applied in the special circumstances of the OTC Drug Review with a degree of flexibility commensurate with the objective of establishing conditions of use under which classes of drugs, rather than individual products, are considered generally recognized as safe and effective." Id. FDA reaffirmed the applicability of the "substantially indistinguishable" standard in 1996, stating that In applying the material extent and material time provision of section 201(p)(2) of the act to determine whether certain conditions were eligible for consideration in the OTC drug monograph system, FDA has... applied a "substantially indistinguishable" standard. 61 FR 51625, (October 3, 1996). This standard has been in effect throughout the period during which the sunscreen monograph, and all other OTC monographs, have been promulgated and implemented by FDA and the regulated industry. The industry has relied on this standard throughout this period for purposes of formulating OTC drug products that are consistent with FDA's interpretation of the law.8 Thus, this standard constitutes a "settled course" of administrative agency behavior. As the Supreme Court has stated (in a case involving the Interstate Commerce Commission) A settled course of behavior embodies the agency's informed judgment that, by pursuing that course, it will carry out the policies committed to it by Congress. There is, then, at least a presumption that those policies will be carried out best if the settled rule is adhered to. Atchison, T. & S. F. R. Co. v. Wichita Bd. of Trade, 412 U. S. 800, (1973). For these reasons, the sunscreen monograph covers any condition for use that is consistent with the terms of the monograph and is substantially indistinguishable from the conditions reviewed by the Advisory Panel. 8 See e.g., T. 0. Henteleff and S. M. Lassman, "Innovating Within the OTC Monograph System," Regulatory Affairs Focus at (March 2000), in which the authors discuss the "substantially indistinguishable" standard as the legal basis for marketing an OTC drug that is not identical to an OTC dmg marketed at the time the monograph was created.

9 Page 9 b. Makeup powder dosage forms are covered by the terms of the sunscreen monograph and are substantially indistinguishable from other topical dosage forms reviewed by the Advisory Panel A makeup powder dosage form is covered by the sunscreen monograph because The terms of the monograph are not dosage-form specific and permit the use of a makeup powder dosage form, and Such a dosage form is substantially indistinguishable from other dosage forms that are accepted by FDA as being covered by the monograph. (1) Makeup powder dosage forms comply with the terms of the sunscreen monograph The monograph's definition of "sunscreen" does not distinguish among dosage forms. It says only that an OTC sunscreen must be "in a form suitable for topical administration." 21 CFR 352.1(a) (stayed). It does not define a "suitable" form or specify permitted inactive ingredients but recognizes that finished dosage forms may vary. The monograph's directions for use also do not distinguish among dosage forms but accommodate variability in dosage forms by stating that, "[m]ore detailed directions applicable to a particular product formulation (e.g, cream, gel, lotion, oil, spray, etc.) may also be included." 21 CFR (d) (stayed). As FDA has said, the monograph "provide[s] that manufacturers can voluntarily expand and supplement these required directions with more detailed instructions applicable to a particular product formulation and dosage form." 58 FR 28194, (May 12, 1993). Most importantly, the monograph does not distinguish among dosage forms in terms of effectiveness but permits the use of any topical dosage form that meets the testing requirements for effectiveness. As FDA has stated, [T]he influence of the vehicle on the effectiveness of a sunscreen drug product is accounted for in the SPF testing procedure because the test is done on the final formulation of a sunscreen product. As provided in Sec , a final sunscreen drug product must have an SPF value of not less than 2. Any product that can demonstrate that it meets the labeled SPF value is considered to be effective. 58 FR 28194, (May 12, 1993). The testing procedures specified by FDA (in its 1999 Final Monograph, its 2007 proposed amendments to the Final Monograph, and its 2011 final sunscreen labeling tule) can be used for many topical dosage forms, including makeup powders.

10 Page 10 In fact, all Bare Escentuals sunscreens in makeup powder dosage form are effective at a level of at least SPF 15. Testing data also demonstrate effectiveness in reducing skin's exposure to UVA radiation. Copies of test reports are provided at Appendix J.9 Therefore, makeup powder dosage forms comply with the terms of the monograph so long as they pass the monograph's efficacy test. 21 CFR Part 352 (stayed). In the same way, makeup powder dosage forms comply with the terms of FDA's new sunscreen labeling rule, 21 CFR (2) Makeup powder dosage forms are substantially indistinguishable from other topical dosage forms reviewed by the Advisory Panel A conclusion that makeup powder dosage forms are substantially indistinguishable from other topical dosage forms reviewed by the Advisory Panel is fully consistent with FDA's articulation of the "substantially indistinguishable" standard in its 1977 letter. In fact, makeup powder dosage forms are more like other topical sunscreen dosage forms than were the products that FDA deemed to be substantially indistinguishable in ) FDA's 1977 letter dealt with potassium nitrite for use as a tooth desensitizer in OTC toothpaste at a concentration of 5 percent. The question was whether this proposed use of potassium nitrite was sufficiently similar to a previously marketed product that it could, as a matter of law, be deemed to have been "used to a material extent [and] for a material time" under 201(p) of the Act. The previously marketed product was "Albion D," a prescription device in the form of a dental tray containing a paste with 8.5 percent potassium nitrite intended for use by dentists or other dental health professionals and not by consumers. FDA stated that, "Mresumably, [Albion D] is intended for occasional use... and not for repeated use." FDA letter to Richardson-Merrell, Inc. (September 23, 1977) (Appendix I). The differences between a makeup powder dosage form and the other topical dosage forms covered by the sunscreen monograph are relatively minor when compared with the differences between OTC potassium nitrite toothpaste and Albion D. In particular, unlike Albion D, all of the relevant sunscreen dosage forms are topically applied to the skin (rather than involving use of a device), use OTC (rather than prescription) levels of active ingredients, and are for regular consumer use (rather than occasional professional use). Indeed, in all material respects, makeup powders are like the lotions, creams, pastes and other dosage forms deemed by FDA to be covered by the sunscreen monograph in that they are rubbed onto the skin, adhere to the skin's surface for a period of time, and are effective at reducing skin's exposure to UVA and UVB radiation. They are particularly similar to water-based lotions 9 All SPF tests were conducted by an independent laboratory using validated procedures in accordance with the test method specified in FDA's 1999 Final Monograph.

11 Page 11 and pastes, which can have the characteristics of powders after the water vehicle evaporates. Based on the standard articulated by FDA, makeup powder dosage forms are substantially indistinguishable from other topical dosage forms reviewed by the Advisory Panel. We are providing with this petition two letters from prominent dermatologists who have considered the question of whether knowledge about the safety and effectiveness of sunscreens in forms accepted by FDA (lotions, creams, gels, etc.) is applicable to the evaluation of sunscreens in powder dosage form. These experts are: Mark G. Lebwohl, M.D., professor and chairman of the Department of Dermatology at The Mount Sinai School of Medicine in New York City. Dr. Lebwohl is a practicing dermatologist and has conducted extensive research on dermatological diseases. He is very familiar with the effects of sunscreens and their importance in reducing the risk of skin cancer and premature aging from exposure to ultraviolet radiation. His letter and curriculum vitae are provided at Appendix K. Howard I. Maibach, M.D., professor in the Department of Dermatology at the University of California, San Francisco. Dr. Maibach has written and conducted extensive research on sunscreen issues. He has been involved in the development of the sunscreen monograph over its more than 30-year history. His letter and curriculum vitae are provided at Appendix L. Dr. Lebwohl states: There is no question that sunscreens in makeup powder dosage form are effective. I have reviewed testing data on UVA and UVB testing conducted by Bare Escentuals and agree that these tests establish that makeup powders can meet the same broad spectrum SPF criteria as all other sunscreens that are acceptable under the monograph. Furthermore, the conditions of use of sunscreen in makeup powder form are similar to those of sunscreens in other dosage forms such as lotions or creams. Specifically, they are intended for short-term topical use in a form that can be readily reapplied to the skin. (In fact, makeup powders have an advantage over other dosage forms because consumers can see color changes that indicate when the sunscreen-containing makeup needs to be reapplied. With other sunscreen dosage forms, consumers do not know when their coverage has been diminished.) Dr. Maibach's views are consistent and he concludes that... makeup powders are not materially different from other sunscreen dosage forms that FDA considers to be covered by the monogyaph (e.g., lotions, creams, gels, etc). The conclusions that the advisory panel and FDA have reached about sunscreens in the course of the development of the monograph are relevant to sunscreens in makeup powder form.

12 Page 12 Accordingly, the use of a makeup powder dosage form does not by itself cause a product to be a "new drug" under 201(p) of the Act and there is no legal basis for concluding that makeup powder dosage forms cannot be covered by the sunscreen monograph. c. Conclusion For the reasons discussed above, although makeup powders are different in form than creams, lotions, pastes, and other topical dosage forms, they are "substantially indistinguishable" from those other dosage forms within the meaning of FDA's 1977 letter. A makeup powder dosage form is "suitable for topical administration" within the meaning of the sunscreen monograph and meets all legal conditions for inclusion in the monograph A conclusion that a makeup powder dosage form is covered by the sunscreen monograph is consistent with FDA's historical approach to the monograph FDA's historical approach to the sunscreen monograph is consistent with a conclusion that a makeup powder dosage form is covered by the terms of the monograph, for the following reasons: In over 30 years of administering the sunscreen monograph, FDA has never previously suggested that makeup powder dosage forms might not be eligible to be covered by the monograph. As discussed in section B.1 above, the 1978 proposed monograph stated that the Advisory Panel considered "... powders... [that] prevent or reduce the passage of the UV radiation" and that "prevent[] sunburn." 43 FR 38206, (August 25, 1978). Further, FDA repeatedly acknowledged that the monograph would cover "make-up products" containing sunscreens. 64 FR 27666, (May 21, 1999). It is common knowledge that many makeup products consist of powders. Thus, FDA has long known that sunscreens in makeup powder form have been marketed to a material extent and for a material time. 11 Until now, FDA has (correctly) never advised manufacturers that makeup powder dosage forms might not be covered by the monograph. Because makeup powder dosage forms fall within the conditions of the original sunscreen monograph, the procedures in 21 CFR , including a time-and-extent application (TEA), are not applicable. As FDA explained when it proposed this regulation, "The agency will continue to use the existing OTC drug review procedures for conditions subject to the original OTC drug review." 64 FR 71062, (December 20, 1999). This conclusion is consistent with the conditions eligible for TEAs as described in section III.0 of FDA's Guidance for Industry Time and Extent Applications for Nonprescription Drug Products (Sept. 2011). 11 See 21 CFR 720.4(c)(7), which defines "makeup preparations" as including "face powders." In 2007, FDA referred to a comment stating that makeup includes foundations, tints, blushes and rouges. 72 FR 49070, (August 27, 2007). These references further indicate that FDA was aware of the presence in the marketplace of sunscreens formulated as makeup powders.

13 Page 13 FDA has encouraged the formulation of sunscreens in makeup form. Because makeup powders are a subset of traditional makeup, FDA has also encouraged the formulation of sunscreens in makeup powder form. FDA has done this by adopting special labeling rules in 21 CFR (f) (stayed) for sunscreens in small packages that are labeled for use on small areas of the face. In the preamble to this Final Monograph, FDA acknowledged the importance of makeup formulations of sunscreen including powder formulations saying, "FDA believes that sunscreen products labeled for use only on small areas of the face... serve an important public health need and FDA does not want to discourage manufacturers from marketing these products..." 72 FR 49070, (August 27, 2007). Thus, until now, FDA has sought to encourage, not discourage, the marketing of sunscreen in makeup form including makeup powders. Based on this history, manufacturers have been justified in concluding that sunscreens in makeup powder dosage form are covered by the monograph. FDA's statements and actions over the last 30 years have supported such a conclusion. FDA' s June 2011 ANPR and Draft Guidance do not set forth an adequate legal or scientific basis for revising this history and reaching a different conclusion. 4. Excluding powder dosage forms from the sunscreen monograph would reduce the number of sunscreens available to consumers for daily use, and would therefore be detrimental to the public health If FDA concludes that powder dosage forms of sunscreens are not eligible for review under the OTC monograph process, this will, as a practical matter, force such products off the market. This result would be detrimental to the public health because it would reduce the number of sunscreens available to consumers for daily use and would eliminate a sunscreen option for persons who prefer this dosage form. According to 2010 data, products formulated as powder sunscreens comprised about 23% of the U.S. market for pressed and loose foundation and powder makeup, and about 9% of the total U.S. market for foundation and powder makeups in all formats. 12 Thus, there are a significant number of these sunscreen products in the marketplace and their loss would mean the loss of a significant sunscreen protection option for consumers. As Dr. Lebwohl states in his letter, it would be "very unfortunate" from a medical and public health perspective if FDA were to remove from the market all OTC sunscreens that are formulated as makeup powders: Effective sun protection requires repeated, combined use of different sunscreen measures. To protect the face, women who wear makeup should be encouraged to combine a variety 12 NPD Market Research Data 2010.

14 Page 14 of measures that will help increase their effective protection. This might include, for example, use of a sunscreen-containing foundation, use of sunscreen-containing makeup powders, use of sun-protective clothing, and remaining indoors when the sun's rays are strongest. Thus, sunscreens in makeup powder form can and do play an important role. Dr. Maibach urges FDA to... encourage, rather than discourage, the marketing of sunscreens in makeup powder dosage forms. This will have a long-term benefit, because just as the applying of makeup is a daily habit these products can help make sunscreen use a daily habit. Both of these experts are concerned that it would be detrimental to the public health if sunscreens were to become unavailable in makeup powder forms. As Dr. Lebwohl states, "In light of the current and projected increased incidence of skin cancer,... manufacturers should be encouraged to formulate more, not fewer, products as sunscreens." 5. Conclusion 111 This petition provides information to support that Powder dosage forms of sunscreens (including makeup powders) were marketed in the United States before the beginning of the OTC Drug Review in 1972, and powder dosage forms were reviewed by the Advisory Panel as part of its assessment of the safety and effectiveness of sunscreens covered by the OTC Drug Review; A makeup powder dosage form is "suitable for topical administration" within the meaning of the sunscreen monograph and meets all legal conditions for inclusion in the monograph; and Considering makeup powder dosage forms to be covered by the monograph would be fully consistent with the history of FDA's implementation of the monograph, and would contribute to protection of the public health. We therefore respectfully request that FDA consider makeup powder dosage forms of OTC sunscreen drug products to be eligible for inclusion in the sunscreen monograph, and to consider such products to be generally recognized as safe and effective when they comply with the sunscreen testing and other applicable requirements of the monograph (and the final sunscreen labeling rule). We appreciate FDA's consideration of this issue and are prepared to meet with the agency and/or respond to any questions the agency may have that would facilitate review of this matter.

15 Page 15 C. Environmental Impact A categorical exclusion from the requirement to prepare an Environmental Assessment or Environmental Impact Statement is claimed under 21 CFR D. Certification The undersigned certifies that, to the best knowledge and belief of the undersigned, this petition includes all information and views on which the petition relies, and that it includes representative data and information known to the petitioner which are unfavorable to the petition. Sincerely, 0,2 (Lk /149, Deanna Chechile Senior Vice President and General Counsel

16 KKB KLEIN-FELD KAPLAN& BECKER, LLP 1140 NINETEENTH STREET, N.W. WASHINGTON, D.C DIVISION OF DOCKETS MANAGEMENT FOOD AND DRUG ADMINISTRATION 5630 FISHERS LANE, ROOM 1061 ROCKVIELLE, MD 20852

February 22, Dear Ms. Hardin,

February 22, Dear Ms. Hardin, February 22, 2016 Kristen Hardin Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 22, Rm. 5443 Silver Spring, MD 20993-0002 RE: Public Comments on Draft

More information

Revised Effectiveness Determination; Sunscreen Drug Products for Over-the-Counter

Revised Effectiveness Determination; Sunscreen Drug Products for Over-the-Counter 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 201 [Docket No. FDA-1978-N-0018] (formerly Docket No. 1978N-0038) RIN 0910-AF43 Revised Effectiveness Determination;

More information

COSMETICS EUROPE: COMMISSION RECOMMENDATION ON THE EFFICACY OF SUNSCREEN PRODUCTS AND THE CLAIMS MADE RELATING THERETO

COSMETICS EUROPE: COMMISSION RECOMMENDATION ON THE EFFICACY OF SUNSCREEN PRODUCTS AND THE CLAIMS MADE RELATING THERETO COSMETICS EUROPE: COMMISSION RECOMMENDATION ON THE EFFICACY OF SUNSCREEN PRODUCTS AND THE CLAIMS MADE RELATING THERETO SEPTEMBER 2006 26.9.2006 Official Journal of the European Union L 265/39 COMMISSION

More information

COSMETICS REFORM EXPLAINED

COSMETICS REFORM EXPLAINED COSMETICS REFORM EXPLAINED 2 BACKGROUND/ INTRO 3 Background/Intro At the Johnson & Johnson & Johnson Family of Consumer Companies, we recognize that consumer confidence is more than a formula, which is

More information

Jaychem Industries Ltd 9/4/15

Jaychem Industries Ltd 9/4/15 Jaychem Industries Ltd 9/4/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 VIA UPS RETURN RECEIPT REQUESTED Warning Letter WL: 320-15-16

More information

Drayton Community Infant School

Drayton Community Infant School Drayton Community Infant School Sun Screen Policy To underpin the values and ethos of our school and our intent to ensure our children/young people are appropriately safeguarded this policy is included

More information

Regulation of Sunscreens in Australia

Regulation of Sunscreens in Australia Regulation of Sunscreens in Australia Dr Cheryl McRae Assistant Secretary Complementary and OTC Medicines Branch The Sunscreen Summit, Brisbane, 19 March 2018 Regulation of Sunscreens in Australia In Australia,

More information

Implementation of GHS Amendment to OSHA HCS American Bakers Association Safety Committee Meeting May 8, 2012

Implementation of GHS Amendment to OSHA HCS American Bakers Association Safety Committee Meeting May 8, 2012 Implementation of GHS Amendment to OSHA HCS American Bakers Association Safety Committee Meeting May 8, 2012 Lawrence P. Halprin Partner Keller and Heckman LLP 1001 G Street, N.W. Washington, DC 20001

More information

Lead in Cosmetic Lip Products and Externally Applied Cosmetics: Recommended Maximum

Lead in Cosmetic Lip Products and Externally Applied Cosmetics: Recommended Maximum This document is scheduled to be published in the Federal Register on 12/22/2016 and available online at https://federalregister.gov/d/2016-30781, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

REFORM THE QUASI-DRUG APPROVAL SYSTEM

REFORM THE QUASI-DRUG APPROVAL SYSTEM REFORM THE QUASI-DRUG APPROVAL SYSTEM Reform the Quasi-Drug Approval System YEARLY STATUS REPORT: Slight Progress In October 2016 and September 2017, MHLW s Evaluation and Licensing Division issued a notification

More information

Sunscreens their special and unique non-gmp requirements. Dusanka Sabic Regulatory Reform Director, Accord Australasia November 2017

Sunscreens their special and unique non-gmp requirements. Dusanka Sabic Regulatory Reform Director, Accord Australasia November 2017 Sunscreens their special and unique non-gmp requirements Dusanka Sabic Regulatory Reform Director, Accord Australasia November 2017 What I will be covering today Sunscreen regulation as cosmetics impact

More information

To view an archived recording of this presentation please click the following link:

To view an archived recording of this presentation please click the following link: To view an archived recording of this presentation please click the following link: http://pho.adobeconnect.com/p1j06jzjerd/ Please scroll down this file to view a copy of the slides from the session.

More information

Sun Protection Policy

Sun Protection Policy Sun Protection Policy Date: September 2016 Review: September 2019 Review Framework: The policy will be reviewed every 3 years (or sooner in the event of revised legislation or guidance) Signed: Headteacher

More information

'Let Your Light Shine' (Matthew 5.v16) Sun Safety Policy. Approval Date: Spring Term 2018

'Let Your Light Shine' (Matthew 5.v16) Sun Safety Policy. Approval Date: Spring Term 2018 'Let Your Light Shine' (Matthew 5.v16) Sun Safety Policy Approval Date: Spring Term 2018 Review Date: Spring Term 2019 OUR MISSION STATEMENT 'Let Your Light Shine' (Matthew 5.v16) At St. Stephen s Church

More information

Over-the-Counter Sunscreens: Safety and Effectiveness Data

Over-the-Counter Sunscreens: Safety and Effectiveness Data Over-the-Counter Sunscreens: Safety and Effectiveness Data Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding

More information

REFORM THE QUASI-DRUG APPROVAL SYSTEM

REFORM THE QUASI-DRUG APPROVAL SYSTEM REFORM THE QUASI-DRUG APPROVAL SYSTEM Reform the Quasi-Drug Approval System YEARLY STATUS REPORT: Slight Progress Having created examination guidelines for medicated shampoos and conditioners in 2014,

More information

Restrictions on the Manufacture, Import, and Sale of Personal Care and Cosmetics Products Containing Plastic Microbeads. Overview

Restrictions on the Manufacture, Import, and Sale of Personal Care and Cosmetics Products Containing Plastic Microbeads. Overview Restrictions on the Manufacture, Import, and Sale of Personal Care and Cosmetics Products Containing Plastic Microbeads Overview In order to facilitate exfoliation and cleaning, enterprises have commonly

More information

Below is the indication and summary of the most serious and most common risks associated with the use of Natroba. 1

Below is the indication and summary of the most serious and most common risks associated with the use of Natroba. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 TRANSMITTED BY FACSIMILE Kerry W. Mettert Director, Quality and Regulatory 11550 North Meridian

More information

REGISTRATIONS APPROVALS LISTINGS PREPARING FOR US FDA INSPECTIONS 483 RESPONSES

REGISTRATIONS APPROVALS LISTINGS PREPARING FOR US FDA INSPECTIONS 483 RESPONSES REGISTRATIONS APPROVALS LISTINGS PREPARING FOR US FDA INSPECTIONS 483 RESPONSES FORMULATIONS & API s MEDICAL DEVICES FOOD FEED DIETARY SUPPLIMENTS COSMETICS United States Agent Services Under the Code

More information

Advertising of Cosmetics

Advertising of Cosmetics Appendix B Advertising of Cosmetics 1. Preamble This section is supplementary to the general provisions of the Code. Special care should be taken by advertisers to ensure that the spirit, as well as the

More information

KoC03of. 510(k) SUMMARY. Lexington International, LLC LaserComb. Submitter's Contact Information. Name: David Michaels, Managing Director JAN

KoC03of. 510(k) SUMMARY. Lexington International, LLC LaserComb. Submitter's Contact Information. Name: David Michaels, Managing Director JAN KoC03of 510(k) SUMMARY Lexington International, LLC LaserComb Submitter's Contact Information Name: David Michaels, Managing Director JAN 1 8 2667 Address: Lexington International, LLC 2650 North Military

More information

(1 rwa. Personal CareNProducts Council. Kristen Hardin. Center for Drug Evaluation and Research, Food and Drug Administration

(1 rwa. Personal CareNProducts Council. Kristen Hardin. Center for Drug Evaluation and Research, Food and Drug Administration Cotm:red a Sc clv I II UI PRODUCTS ASSOCIATION Quc!jiy & Innovoion Kristen Hardin 10903 New Hampshire Avenue, Building 22, Room 5443 Silver Spring, MD 20993 2018) The Personal Care Products Council (Council)

More information

Dr. Matteo Zanotti Russo

Dr. Matteo Zanotti Russo Dr. Matteo Zanotti Russo Angel Consulting - Italy CRCC Berlin, October 2017 What s on EU Commission Report on product claims Are we complying with EU Regulation no. 655/2013 What are Authorities inspecting?

More information

REFORM THE QUASI-DRUG APPROVAL SYSTEM

REFORM THE QUASI-DRUG APPROVAL SYSTEM REFORM THE QUASI-DRUG APPROVAL SYSTEM Reform the Quasi-Drug Approval System YEARLY STATUS REPORT: Progress The Ministry of Health, Labour and Welfare (MHLW) released a model template for ordinary quasi-drug

More information

Sun Protection Policy

Sun Protection Policy Raftons Road Bangalow NSW 2479 Email: kidcare@bigpond.com Phone: 02 6687 1552 Fax: 02 6687 2666 Sun Protection Policy Reviewed December 2017 Legislation: Education and Care Services National Regulation

More information

Understanding the new FDA Sunscreen Labeling Changes

Understanding the new FDA Sunscreen Labeling Changes Understanding the new FDA Sunscreen Labeling Changes Brought to you by: Understanding the FDA sunscreen labeling changes n I n June 2011, the U.S. Food and Drug Administration (FDA) announced final rulings

More information

Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD September 2000 (FDA)

Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD September 2000 (FDA) Department of Health and Human Services Food and Drug Administration 5600 Fishers Lane (HFI-40) Rockville, MD 20857 September 2000 (FDA) 99-1279 When Outside in The Sun The Food and Drug Administration,

More information

September 23, Dear Dr. Hamburg:

September 23, Dear Dr. Hamburg: September 23, 2011 Dr. Margaret A. Hamburg, M.D. Commissioner of Food and Drugs U.S. Food and Drug Administration 10903 New Hampshire Ave Silver Spring, MD 20993-0002 Dear Dr. Hamburg: On behalf of the

More information

Sunscreen

Sunscreen Sunscreen Most people today are aware of at least some of the damaging effects that sunlight has on the skin. In addition to painful sunburns, excessive exposure to sunlight can cause sun damage that prematurely

More information

H 7915 S T A T E O F R H O D E I S L A N D

H 7915 S T A T E O F R H O D E I S L A N D LC00 0 -- H S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 0 A N A C T RELATING TO FOOD AND DRUGS - RHODE ISLAND FOOD, DRUGS, AND COSMETICS ACT Introduced By: Representatives

More information

Philadelphia University Faculty of Pharmacy Department of Pharmaceutical Sciences First Semester, 2017/2018. Course Syllabus. Course code:

Philadelphia University Faculty of Pharmacy Department of Pharmaceutical Sciences First Semester, 2017/2018. Course Syllabus. Course code: Philadelphia University Faculty of Pharmacy Department of Pharmaceutical Sciences First Semester, 2017/2018 Course Syllabus Course Title: Cosmetics Course Level: 5 th year Course code: 0520420 Course prerequisite

More information

SunSmart Policy RQI Board Endorsed - 13 July 2010

SunSmart Policy RQI Board Endorsed - 13 July 2010 SunSmart Policy RQI Board Endorsed - 13 July 2010 Rationale Queensland has the highest rate of skin cancer in the world. Of all new cancers diagnosed in Australia each year, 80 per cent are skin cancers.

More information

Cosmetic product claims

Cosmetic product claims Cosmetic product claims Regulatory framework and the common criteria Manuela Coroama Cosmetics Europe Contents 1. Introduction 2. The EU regulatory framework for cosmetic product claims 3. The scope of

More information

SOUTH AFRICAN NATIONAL STANDARD

SOUTH AFRICAN NATIONAL STANDARD ISBN 978-0-626-29618-6 SOUTH AFRICAN NATIONAL STANDARD Sunscreen products WARNING This document references other documents normatively. Published by SABS Standards Division 1 Dr Lategan Road Groenkloof

More information

Sun Protection Behaviours in Primary Care. Dr. Christie Freeman Dr. Lisa Graves Dr. Patricia Mousmanis

Sun Protection Behaviours in Primary Care. Dr. Christie Freeman Dr. Lisa Graves Dr. Patricia Mousmanis Sun Protection Behaviours in Primary Care Dr. Christie Freeman Dr. Lisa Graves Dr. Patricia Mousmanis FMF 2015 1 What talk about sun protection? Skin cancer is the most common cancer diagnosis in Canada

More information

Australian/New Zealand Standard

Australian/New Zealand Standard AS/NZS 2604:2012 AS/NZS 2604:2012 Australian/New Zealand Standard Sunscreen products Evaluation and classification AS/NZS 2604:2012 This Joint Australian/New Zealand Standard was prepared by Joint Technical

More information

United States Standards for Grades of Cucumbers

United States Standards for Grades of Cucumbers Marketing and Regulatory Programs Agricultural Marketing Service Specialty Crops Program Specialty Crops Inspection Division United States Standards for Grades of Cucumbers Effective September 6, 2016

More information

AS/NZS 4399:1996 AS/NZS

AS/NZS 4399:1996 AS/NZS AS/NZS 4399:2017 Australian/New Zealand Standard Sun protective clothing Evaluation and classification Superseding AS/NZS 4399:1996 AS/NZS 4399:2017 AS/NZS 4399:2017 This joint Australian/New Zealand standard

More information

SANITARY REQUIREMENTS FOR TATTOO & BODY PIERCING ESTABLISHMENTS

SANITARY REQUIREMENTS FOR TATTOO & BODY PIERCING ESTABLISHMENTS SANITARY REQUIREMENTS FOR TATTOO & BODY PIERCING ESTABLISHMENTS A REGULATION OF THE BOARD OF HEALTH OF THE MAHONING COUNTY GENERAL HEALTH DISTRICT ESTABLISHING REGISTRATION REQUIREMENTS FOR TATTOO & BODY

More information

FACTS. about MemoryGel silicone gel-filled breast implants

FACTS. about MemoryGel silicone gel-filled breast implants FACTS about MemoryGel silicone gel-filled breast implants Are you considering breast implant surgery but not certain which type of implant to choose? YOU RE NOT ALONE. Science-based information to empower

More information

Evaluation of Cosmeceutical Ingredients: What the Label May Not Reveal Patrick Bitter, MD. Regulation of Topical Skin Care Products.

Evaluation of Cosmeceutical Ingredients: What the Label May Not Reveal Patrick Bitter, MD. Regulation of Topical Skin Care Products. Evaluation of Cosmeceutical Ingredients: What the Label May Not Reveal Patrick Bitter, MD Regulation of Topical Skin Care Products US Food and Drug Administration (FDA) recognizes two categories of products

More information

Germanna Community College Policy 70210: Hazard Communication Plan

Germanna Community College Policy 70210: Hazard Communication Plan 1. Purpose Germanna Community College Policy 70210: Hazard Communication Plan 1.1. To establish guidelines and policies to make Germanna Community College employees aware of chemical hazards to which they

More information

Understand wellness, disease prevention, and recognition of symptoms. ESSENTIAL STANDARD - 7. PCH.1

Understand wellness, disease prevention, and recognition of symptoms. ESSENTIAL STANDARD - 7. PCH.1 Understand wellness, disease prevention, and recognition of symptoms. ESSENTIAL STANDARD - 7. PCH.1 7.PCH.1.2 Explain environmental, psychological, and social factors affecting excessive sun exposure CLARIFYING

More information

March 2013 ==================== Jason B. Lichten, M.D., FACS

March 2013 ==================== Jason B. Lichten, M.D., FACS March 2013 Jason B. Lichten, M.D., FACS I hope you're giving your complexion lots of TLC before and after your treatments here at our office. A key element in that care is using excellent topical lotions.

More information

OTC Sunscreen Drug Products: Towards Greater Protection

OTC Sunscreen Drug Products: Towards Greater Protection OTC Sunscreen Drug Products: Towards Greater Protection The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Accessed Citable

More information

This lab is estimated to take 1 to 1.5 hours.

This lab is estimated to take 1 to 1.5 hours. MoDRN Module: Oxybenzone versus Zinc Oxide in Sunscreen for Biology Classrooms Teacher s Notes This lab is estimated to take 1 to 1.5 hours. Oxybenzone is used in chemical- based sunscreens as a photoprotective

More information

I wanted to take this moment to respond to your inquiries on ingredient safety.

I wanted to take this moment to respond to your inquiries on ingredient safety. I wanted to take this moment to respond to your inquiries on ingredient safety. EWG and other less reputable websites use scare tactics. Many scientists, including myself, volunteered to help improve EWG-Skin

More information

St. Gregory s Catholic Primary School. Sun Policy

St. Gregory s Catholic Primary School. Sun Policy St. Gregory s Catholic Primary School Sun Policy A School Sun Safety policy The aim of the sun safety policy is to protect children and staff from skin damage caused by the effects of ultraviolet radiation

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Page 1 of 6 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Keystone Laboratories

More information

EASTERN KENTUCKY UNIVERSITY HAZARD COMMUNICATION PROGRAM SUMMARY COMPLIANCE MANUAL. Table of Contents

EASTERN KENTUCKY UNIVERSITY HAZARD COMMUNICATION PROGRAM SUMMARY COMPLIANCE MANUAL. Table of Contents EASTERN KENTUCKY UNIVERSITY HAZARD COMMUNICATION PROGRAM SUMMARY COMPLIANCE MANUAL Table of Contents I. OVERVIEW OF THE HAZARD COMMUNICATION STANDARD A. Background and Scope.................................

More information

Australian/New Zealand Standard

Australian/New Zealand Standard AS/NZS 4399:2017 AS/NZS 4399:2017 Australian/New Zealand Standard Sun protective clothing Evaluation and classification AS/NZS 4399:2017 This Joint Australian/New Zealand Standard was prepared by Joint

More information

EU position on cosmetics in TTIP Comparison between 2014 and 2015 versions

EU position on cosmetics in TTIP Comparison between 2014 and 2015 versions EU position on cosmetics in TTIP Comparison between 2014 and 2015 versions May 2014 March 2015 1. Introduction The final report of the US - EU High Level Working Group on Jobs and Growth of February 2013

More information

Presented by Industrial Sunscreen. Intro Video >

Presented by Industrial Sunscreen. Intro Video > Presented by Industrial Sunscreen Intro Video > Scorched by the Sun 90% More than 90 percent of the visible changes commonly attributed to skin aging are caused by the sun 24% People who use sunscreen

More information

Your Kids and the Sun

Your Kids and the Sun Your Kids and the Sun Please click on any of the links below to go directly to your specified topic within this document. How Does the Sun Harm Our Skin? Some Skin Cancers Can Be Deadly Childhood Sun Protection

More information

We understand that a competitor has raised the following issues which we will address in this letter.

We understand that a competitor has raised the following issues which we will address in this letter. March 01, 2010 Dear Customer, Thank you for your recent inquiry into PURELL Waterless Surgical Scrub. PURELL is an effective surgical scrub formulation that meets the requirements of the surgical scrub

More information

Hazard Communication and the Globally Harmonized System (GHS) John Frowd, CAS USDOL-OSHA Manhattan Area Office

Hazard Communication and the Globally Harmonized System (GHS) John Frowd, CAS USDOL-OSHA Manhattan Area Office Hazard Communication and the Globally Harmonized System (GHS) John Frowd, CAS USDOL-OSHA Manhattan Area Office Frowd.john@dol.gov Brief Overview/GHS Learning Objectives Why Adopt the GHS Description of

More information

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 117 Cosmetology SPONSOR(S): Carroll TIED BILLS: IDEN./SIM. BILLS: SB 920 REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Jobs & Entrepreneurship Council 2)

More information

Sunscreen Safety. Dr Theone Papps, MBBS A/Prof Stephen Shumack, OAM FACD

Sunscreen Safety. Dr Theone Papps, MBBS A/Prof Stephen Shumack, OAM FACD Sunscreen Safety Dr Theone Papps, MBBS A/Prof Stephen Shumack, OAM FACD Outline Sunscreen safety: Application Reactions Publicity Nanoparticles?Oestrogen absorption?free radicals and cancer?environmental

More information

RULES OF TENNESSEE BOARD OF COSMETOLOGY AND BARBER EXAMINERS CHAPTER SANITARY REQUIREMENTS TABLE OF CONTENTS

RULES OF TENNESSEE BOARD OF COSMETOLOGY AND BARBER EXAMINERS CHAPTER SANITARY REQUIREMENTS TABLE OF CONTENTS RULES OF TENNESSEE BOARD OF COSMETOLOGY AND BARBER EXAMINERS CHAPTER 0200-03 SANITARY REQUIREMENTS TABLE OF CONTENTS 0200-03-.01 Applicability 0200-03-.02 Violations 0200-03-.03 Location 0200-03-.04 Communicable

More information

Cosmetic Defined in FD&C Act, Section 201 (i) Articles intended for: Cleansing Beautifying Promoting attractiveness Altering the appearance Excludes S

Cosmetic Defined in FD&C Act, Section 201 (i) Articles intended for: Cleansing Beautifying Promoting attractiveness Altering the appearance Excludes S Cosmetics and Color Additives Personal Care Product Council GMP Workshop November 10, 2010 Presented by Richard Chiang Compliance Manager FDA Los Angeles Import Operations Cosmetics Scope Used by most

More information

SANITARY REQUIREMENTS FOR TATTOO & BODY PIERCING ESTABLISHMENTS

SANITARY REQUIREMENTS FOR TATTOO & BODY PIERCING ESTABLISHMENTS SANITARY REQUIREMENTS FOR TATTOO & BODY PIERCING ESTABLISHMENTS A REGULATION OF THE BOARD OF HEALTH OF THE MAHONING COUNTY GENERAL HEALTH DISTRICT ESTABLISHING REGISTRATION REQUIREMENTS FOR TATTOO & BODY

More information

Will FDA Get New Authority to Regulate Cosmetics?

Will FDA Get New Authority to Regulate Cosmetics? July 3, 2012 Authors: Mark N. Duvall 1350 I Street, NW Suite 700 Washington, DC 20005 (202) 789-6090 mduvall@bdlaw.com Introduction Will FDA Get New Authority to Regulate Cosmetics? Drug and medical device

More information

Be Sun Savvy! Coaches Manual

Be Sun Savvy! Coaches Manual Be Sun Savvy! Coaches Manual *Some manual content was obtained from the Dartmouth-Hitchcock Norris Cotton Cancer Center. *Other sources include the Skin Cancer Foundation, Centers for Centers for Disease

More information

IT S TIME TO... COMBAT OCCUPATIONAL SKIN DISEASE

IT S TIME TO... COMBAT OCCUPATIONAL SKIN DISEASE IT S TIME TO... COMBAT OCCUPATIONAL SKIN DISEASE The Deb Skin Care Programme OCCUPATIONAL SKIN DISEASE AN INVISIBLE THREAT to Efficiency, Health & Well-being Occupational skin disease is a serious health

More information

FDA ISSUES 12/19/2012 SPECIFIC PROMOTIONAL PRODUCTS ISSUES

FDA ISSUES 12/19/2012 SPECIFIC PROMOTIONAL PRODUCTS ISSUES FDA ISSUES How To Stay on the Sweet Side of the Law; FDA Issues that affect the Promotional Products Industry SPECIFIC PROMOTIONAL PRODUCTS ISSUES FOOD (including confectionaries, i.e. candy, gum, mints,

More information

BSD High School Health

BSD High School Health BSD High School Health Sunscreen Lab Brief Description Using prior knowledge from previous lessons, students will gain a better understanding of Exposure through this Sunscreen Lab. Upon completion of

More information

S051: Dilemmas in Skin Cancer Dilemmas Associated with Oxybenzone in Sunscreens

S051: Dilemmas in Skin Cancer Dilemmas Associated with Oxybenzone in Sunscreens S051: Dilemmas in Skin Cancer Dilemmas Associated with Oxybenzone in Sunscreens Henry W. Lim, MD Department of Dermatology Senior Vice President for Academic Affairs Henry Ford Hospital, Detroit, Michigan

More information

Page 1 of 5 A to Z Index En español Contact Us FAQs About OSHA OSHA Newsletter RSS Feeds Print This Page Text Size Was this page helpful? What's New Offices Home Workers Regulations Enforcement Data &

More information

Moderate exposure to UV is essential for a healthy life

Moderate exposure to UV is essential for a healthy life UV & Our Skin Ultraviolet (UV) light is invisible light that radiates from the sun and can also be created by some artificial sources Moderate exposure to UV is essential for a healthy life Human skin

More information

1. Certificates of compliance to SA8000:2014 become available starting May 1, 2015.

1. Certificates of compliance to SA8000:2014 become available starting May 1, 2015. SOCIAL ACCOUNTABILITY ACCREDITATION SERVICES SAAS Notification Issue: 4 Date: November 25, 2014 To: All SAAS Accredited and Applicant Certification Bodies From: Rochelle Zaid, Executive Director, SAAS

More information

Your skin needs sun protection every day 1

Your skin needs sun protection every day 1 Your skin needs sun protection every day 1 When you re not wearing sunscreen daily to help preserve your skin s health, UVA and UVB rays can cause the following damage: Skin reddening and sunburn 2 Brown

More information

ASMI COMPLAINTS PANEL FINAL DETERMINATION Meeting held 10 November, 2009

ASMI COMPLAINTS PANEL FINAL DETERMINATION Meeting held 10 November, 2009 ASMI COMPLAINTS PANEL FINAL DETERMINATION Meeting held 10 November, 2009 Hamilton Laboratories ( HL ) v. Johnson & Johnson Pacific ( JJP ) Neutrogena Ultra Sheer Dry-Touch Sunscreen Lotion 1. HL complains

More information

MOTION FOR A RESOLUTION

MOTION FOR A RESOLUTION European Parliament 2014-2019 Plenary sitting B8-0217/2018 25.4.2018 MOTION FOR A RESOLUTION further to Questions for Oral Answer B8-0017/2018 and B8-0018/2018 pursuant to Rule 128(5) of the Rules of Procedure

More information

RISKS AND HEALTH EFFECTS FROM TATTOOS, BODY PIERCING AND RELATED PRACTICES

RISKS AND HEALTH EFFECTS FROM TATTOOS, BODY PIERCING AND RELATED PRACTICES THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONSULTATION CONCERNING RISKS AND HEALTH EFFECTS FROM TATTOOS, BODY PIERCING AND RELATED PRACTICES adopted by

More information

A Real Burn: Sunscreen Labeling in the Face of FDA Inaction

A Real Burn: Sunscreen Labeling in the Face of FDA Inaction A Real Burn: Sunscreen Labeling in the Face of FDA Inaction The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Accessed

More information

Does anti ageing advertising have a future?

Does anti ageing advertising have a future? Does anti ageing advertising have a future? Dr. Chris Gummer chrisgummer@cidersolutions.co.uk 00 44 (0)7786333602 The conundrum and who s to blame! Cosmetics Borderline Medicines (disease and diagnosis)

More information

SunWise. a program that radiates good ideas. Grades 6-8. SunWise. U.S. Environmental Protection Agency 6-8

SunWise. a program that radiates good ideas.   Grades 6-8. SunWise. U.S. Environmental Protection Agency 6-8 a program that radiates good ideas www.epa.gov/sunwise Grades U.S. Environmental Protection Agency 1 Be 2 What do you know about the Sun? 3 The Sun Helpful Keeps Us Warm Harmful Causes Sunburns Helps Plants

More information

University of Wisconsin-Madison Hazard Communication Standard Policy Dept. of Environment, Health & Safety Office of Chemical Safety

University of Wisconsin-Madison Hazard Communication Standard Policy Dept. of Environment, Health & Safety Office of Chemical Safety University of Wisconsin-Madison Hazard Communication Standard Policy Dept. of Environment, Health & Safety Office of Chemical Safety 1.0 Introduction... 1 1.1 Purpose... 1 1.2 Regulatory Background...

More information

Cosmetic Products New EU Regulation Published

Cosmetic Products New EU Regulation Published Cosmetic Products New EU Regulation Published From 11th July 2013 cosmetic products placed on the market within the European Economic Area1 (EEA) will have to comply with the new EU Cosmetic Products Regulation

More information

To : Mr. Martin Welz At : Noseweek : Date : 16 July 2012

To : Mr. Martin Welz At : Noseweek : Date : 16 July 2012 To : Mr. Martin Welz At : Noseweek : Date : 16 July 2012 Dear Mr. Welz, SUNSCREENS TESTED IN SOUTH AFRICA & REVISED SUNSCREEN STANDARDS CLAIM CONTEXT We are in receipt of your letter dd 11/7/12. CANSA

More information

Trustees of Dartmouth College

Trustees of Dartmouth College Trustees of Dartmouth College p.2 Project Background SunSafe in the Middle School Years was a research project aimed at improving sun protection in middle school students. Funded by the National Cancer

More information

ASKANESTHETICIAN'S BLOG. What Are Cosmeceuticals? January 17, categories. 1 de 6 02/09/ :00 ABOUT

ASKANESTHETICIAN'S BLOG. What Are Cosmeceuticals? January 17, categories. 1 de 6 02/09/ :00 ABOUT ASKANESTHETICIAN'S ABOUT BLOG An esthetician explores skincare issues and concerns What Are Cosmeceuticals? January 17, 2011 Filed under: Beauty/Cosmetic Products,Skincare products askanesthetician @ 9:55

More information

Wellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 4: Sun Safety

Wellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 4: Sun Safety Wellness Along the Cancer Journey: Healthy Habits and Cancer Screening Revised October 2015 Chapter 4: Sun Safety Healthy Habits and Cancer Screening Rev 10.20.15 Page 191 Sun Safety Group Discussion 1)

More information

What's the difference?

What's the difference? Raise your hand if you walk down the sunscreen aisle and immediately feel overwhelmed? (Us too!) From sprays to lotions, gels to oils, the options are endless, and the results? Well, unfortunately they

More information

BELINDA CASTLES SUNSCREEN SUMMIT 19 TH MARCH 2018

BELINDA CASTLES SUNSCREEN SUMMIT 19 TH MARCH 2018 BELINDA CASTLES SUNSCREEN SUMMIT 19 TH MARCH 2018 ABOUT CONSUMER NZ We have over 50 years experience of providing trusted, independent and accurate advice. We re free of advertising and commercial pressures.

More information

FINAL DRAFT UGANDA STANDARD

FINAL DRAFT UGANDA STANDARD FINAL DRAFT UGANDA STANDARD FDUS EAS 377-1 First Edition 2013-mm-dd Cosmetics and cosmetic products Part 1: List of substances prohibited in cosmetic products Reference number FDUS EAS 377-1: 2013 UNBS

More information

According to the INDICATIONS AND USAGE section of its FDA-approved product labeling (PI) (emphasis in original):

According to the INDICATIONS AND USAGE section of its FDA-approved product labeling (PI) (emphasis in original): DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 TRANSMITTED BY FACSIMILE Bhavana Desai Senior Director, Advertising and Promotional Compliance

More information

CHAPTER Committee Substitute for House Bill No. 729

CHAPTER Committee Substitute for House Bill No. 729 CHAPTER 2010-220 Committee Substitute for House Bill No. 729 An act relating to the practice of tattooing; creating s. 381.00771, F.S.; defining terms; creating s. 381.00773, F.S.; exempting certain personnel

More information

Australian Standard. Sunglasses and fashion spectacles. Part 1: Safety requirements AS

Australian Standard. Sunglasses and fashion spectacles. Part 1: Safety requirements AS AS 1067.1 1990 Australian Standard Sunglasses and fashion spectacles Part 1: Safety requirements This Australian Standard was prepared by Committee CS/53, Sunglasses. It was approved on behalf of the Council

More information

Product Information File & Cosmetic Product Safety Report

Product Information File & Cosmetic Product Safety Report Product Information File & Cosmetic Product Safety Report October 2015 Compliance with Cosmetic Regulation EC No. 1223/2009 Product Information File and Cosmetic Product Safety Report Regulation EC No.

More information

Clinical Policy: Lindane Shampoo Reference Number: CP.PMN.09 Effective Date: Last Review Date: Line of Business: Oregon Health Plan

Clinical Policy: Lindane Shampoo Reference Number: CP.PMN.09 Effective Date: Last Review Date: Line of Business: Oregon Health Plan Clinical Policy: Lindane Shampoo Reference Number: CP.PMN.09 Effective Date: 10.01.18 Last Review Date: 07.13.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the end of this

More information

Provide UV tanning Unit 312 1

Provide UV tanning Unit 312 1 312 Provide UV tanning It s very important for anyone wanting to have a UV tanning treatment to get the correct advice that only an expert can give. For many people, a tan makes them feel and look healthier

More information

ASIAN SKIN: ROLE OF UVA IN HYPERPIGMENTATION AND PREVENTION

ASIAN SKIN: ROLE OF UVA IN HYPERPIGMENTATION AND PREVENTION 1 RESEARCH & INNOVATION ASIAN SKIN: ROLE OF UVA IN HYPERPIGMENTATION AND PREVENTION Dominique MOYAL SUN PROTECTION & ANTI-AGEING SKIN CARE ASIA CONFERENCE 2014 CONTENT OF THE PRESENTATION The effects of

More information

By Angela Batluck, Associate Editor. June 2005 Practical Dermatology 31

By Angela Batluck, Associate Editor. June 2005 Practical Dermatology 31 Separating average sunscreens from the good ones doesn t have to be difficult. Experts share insight on ingredients, labels, and topical antioxidants. By Angela Batluck, Associate Editor June 2005 Practical

More information

Charles W. Eisemann Center Forrest & Virginia Green Mezzanine-Gallery Policies & Procedures for Exhibiting

Charles W. Eisemann Center Forrest & Virginia Green Mezzanine-Gallery Policies & Procedures for Exhibiting I. Application and Submitting of Proposals Charles W. Eisemann Center Forrest & Virginia Green Mezzanine-Gallery Policies & Procedures for Exhibiting A. Submittal Process for Exhibiting Artists or organizations

More information

Urgent need for greater oversight of SPF claims, including manufacturers testing methodology and use of inactive sunscreen ingredients

Urgent need for greater oversight of SPF claims, including manufacturers testing methodology and use of inactive sunscreen ingredients August 18, 2016 The Honorable Robert M. Califf, MD Commissioner U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Re: Urgent need for greater oversight of SPF claims,

More information

SPF 30 Mineral Powder Sunscreen

SPF 30 Mineral Powder Sunscreen SPF 30 Mineral Powder Sunscreen 2016 Andrea Wetsel, CEO and Founder of Brush On Block I fell in love with the idea of making sun protection easy and convenient for the whole family Brush On Block SPF 30

More information

SUN therapè TOTAL CARE SUN PROTECTANT PROFESSIONAL QUALITY AVAILABLE IN PROISPORT FORMULAS

SUN therapè TOTAL CARE SUN PROTECTANT PROFESSIONAL QUALITY AVAILABLE IN PROISPORT FORMULAS SUN therapè PRO SPORT TOTAL CARE SUN PROTECTANT PROFESSIONAL QUALITY AVAILABLE IN PROISPORT FORMULAS Market Position For 25 years, Pharmagel skin care has been the NUMBER ONE choice of independent beauty

More information

New Mexico Institute of Mining & Technology. Hazard Communication Policy

New Mexico Institute of Mining & Technology. Hazard Communication Policy New Mexico Institute of Mining & Technology Hazard Communication Policy BASIS: The OSHA Hazard Communication Standard establishes uniform requirements to ensure that the hazards of all chemicals used at

More information

Arkansas Department of Finance & Administration Rule Comments

Arkansas Department of Finance & Administration Rule Comments Save money. live better. 702 SW 8th Street BenlOnville. AR 727111 Phone '19 ~ _ 2178 Fax 866 31 1 7270 wwwwa!martcom Arkansas Department of Finance & Administration Rule 2012-2 Comments 1. requests that

More information